BioSpace News Archive

- An estimated 15% to 20% of the Turkish population suffers from the difficulty of conceiving - “As the world’s only Intravaginal Culture System, INVOcell, a streamlined treatment solution, is uniquely positioned to address the challenges within the infertility industry.” [16-July-2020] SARASOTA, Fla. , July 16, 2020 /PRNewswire/ -- INVO Bioscience

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced biotech veteran Harry J. Leonhardt, Esq. has joined the company as General Counsel and Chief Com

Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the appointment of Leslie Grab as VP of Intellectual Property and John Lyle as VP of Assay Research and Development.

Dr. Stephen Brigido has joined NEXGEL’s Scientific Advisory Board. Dr. Brigido will participate with and advise the Company regarding its clinical and over-the-counter commercial development of new products created from NEXGEL’s hydrogel technology.

Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.

Promega Corporation’s Maxwell ® RSC 48 Instrument and Maxwell ® RSC Viral Total Nucleic Acid Purification Kit (Maxwell Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July 13, 2020, the U.S. Food and Drug Administration (FDA) auth

Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 150,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.

Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced the appointment of two pharmaceutical veterans to its executive leadership team: Sesha Neerva

Innate Pharma SA announced the appointment of Dr. Joyson Karakunnel as Executive Vice President and Chief Medical Officer.

OSE Immunotherapeutics announced it will receive a grant of up to €200,000 from Nantes Metropole, the metropolitan area of Nantes community, dedicated to the development of a prophylactic vaccine against the pandemic virus SARS-CoV-2.